HEADER TRANSPORT PROTEIN 02-OCT-13 4C9J TITLE STRUCTURE OF YEAST MITOCHONDRIAL ADP/ATP CARRIER ISOFORM 3 INHIBITED TITLE 2 BY CARBOXYATRACTYLOSIDE (P212121 CRYSTAL FORM) COMPND MOL_ID: 1; COMPND 2 MOLECULE: ADP, ATP CARRIER PROTEIN 3; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: ADP-ATP CARRIER ISOFORM 3, ADP/ATP TRANSLOCASE 3, ADENINE COMPND 5 NUCLEOTIDE TRANSLOCATOR 3, ANT 3; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SACCHAROMYCES CEREVISIAE; SOURCE 3 ORGANISM_COMMON: BAKER'S YEAST; SOURCE 4 ORGANISM_TAXID: 4932; SOURCE 5 EXPRESSION_SYSTEM: SACCHAROMYCES CEREVISIAE; SOURCE 6 EXPRESSION_SYSTEM_COMMON: BAKER'S YEAST; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 4932; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: WB12; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_VECTOR: PYES3 KEYWDS MITOCHONDRIAL CARRIER, TRANSPORT PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR J.J.RUPRECHT,A.M.HELLAWELL,M.HARDING,P.G.CRICHTON,A.J.MCCOY, AUTHOR 2 E.R.S.KUNJI REVDAT 4 20-DEC-23 4C9J 1 REMARK REVDAT 3 12-FEB-14 4C9J 1 JRNL REVDAT 2 05-FEB-14 4C9J 1 JRNL REVDAT 1 22-JAN-14 4C9J 0 JRNL AUTH J.J.RUPRECHT,A.M.HELLAWELL,M.HARDING,P.G.CRICHTON,A.J.MCCOY, JRNL AUTH 2 E.R.S.KUNJI JRNL TITL STRUCTURES OF YEAST MITOCHONDRIAL ADP/ATP CARRIERS SUPPORT A JRNL TITL 2 DOMAIN-BASED ALTERNATING-ACCESS TRANSPORT MECHANISM JRNL REF PROC.NATL.ACAD.SCI.USA V. 111 E426 2014 JRNL REFN ISSN 0027-8424 JRNL PMID 24474793 JRNL DOI 10.1073/PNAS.1320692111 REMARK 2 REMARK 2 RESOLUTION. 3.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 38.98 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 3 NUMBER OF REFLECTIONS : 9415 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.252 REMARK 3 R VALUE (WORKING SET) : 0.250 REMARK 3 FREE R VALUE : 0.297 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.700 REMARK 3 FREE R VALUE TEST SET COUNT : 443 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 38.9795 - 4.8979 0.99 3109 159 0.2742 0.3378 REMARK 3 2 4.8979 - 3.8887 1.00 2990 142 0.2315 0.2532 REMARK 3 3 3.8887 - 3.3975 0.98 2873 142 0.2388 0.2931 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.360 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 29.230 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 52.23 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.002 4485 REMARK 3 ANGLE : 0.827 6058 REMARK 3 CHIRALITY : 0.043 681 REMARK 3 PLANARITY : 0.002 731 REMARK 3 DIHEDRAL : 16.968 1681 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : 1 REMARK 3 NCS GROUP : 1 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: RESIDUES 151-155 AND 205-219 OF CHAIN REMARK 3 A, AND 152-155 AND 204-219 OF CHAIN B, ARE UNMODELLED OWING TO REMARK 3 POOR DENSITY REMARK 4 REMARK 4 4C9J COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 02-OCT-13. REMARK 100 THE DEPOSITION ID IS D_1290058617. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-DEC-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.8726 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 9455 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.400 REMARK 200 RESOLUTION RANGE LOW (A) : 49.340 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 6.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 200 DATA REDUNDANCY : 3.900 REMARK 200 R MERGE (I) : 0.25000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 5.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.67 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.6 REMARK 200 DATA REDUNDANCY IN SHELL : 4.00 REMARK 200 R MERGE FOR SHELL (I) : 0.72000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 4C9G REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.80 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.30 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M TRIS PH 8.5, 20MM SODIUM CITRATE, REMARK 280 10% T-BUTANOL, 28% PEG400 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 20.14300 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 77.07150 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 52.08400 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 77.07150 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 20.14300 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 52.08400 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -14 REMARK 465 HIS A -13 REMARK 465 HIS A -12 REMARK 465 HIS A -11 REMARK 465 HIS A -10 REMARK 465 HIS A -9 REMARK 465 HIS A -8 REMARK 465 HIS A -7 REMARK 465 HIS A -6 REMARK 465 HIS A -5 REMARK 465 ILE A -4 REMARK 465 GLU A -3 REMARK 465 GLY A -2 REMARK 465 ARG A -1 REMARK 465 SER A 0 REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 SER A 3 REMARK 465 ASP A 4 REMARK 465 ALA A 5 REMARK 465 LYS A 6 REMARK 465 GLN A 7 REMARK 465 GLN A 8 REMARK 465 GLU A 9 REMARK 465 SER A 151 REMARK 465 LYS A 152 REMARK 465 LYS A 153 REMARK 465 GLY A 154 REMARK 465 GLY A 155 REMARK 465 PRO A 205 REMARK 465 LEU A 206 REMARK 465 VAL A 207 REMARK 465 LEU A 208 REMARK 465 THR A 209 REMARK 465 GLY A 210 REMARK 465 SER A 211 REMARK 465 LEU A 212 REMARK 465 ASP A 213 REMARK 465 GLY A 214 REMARK 465 SER A 215 REMARK 465 PHE A 216 REMARK 465 LEU A 217 REMARK 465 ALA A 218 REMARK 465 SER A 219 REMARK 465 LYS A 307 REMARK 465 MET B -14 REMARK 465 HIS B -13 REMARK 465 HIS B -12 REMARK 465 HIS B -11 REMARK 465 HIS B -10 REMARK 465 HIS B -9 REMARK 465 HIS B -8 REMARK 465 HIS B -7 REMARK 465 HIS B -6 REMARK 465 HIS B -5 REMARK 465 ILE B -4 REMARK 465 GLU B -3 REMARK 465 GLY B -2 REMARK 465 ARG B -1 REMARK 465 SER B 0 REMARK 465 MET B 1 REMARK 465 ALA B 2 REMARK 465 SER B 3 REMARK 465 ASP B 4 REMARK 465 ALA B 5 REMARK 465 LYS B 6 REMARK 465 GLN B 7 REMARK 465 GLN B 8 REMARK 465 GLU B 9 REMARK 465 THR B 10 REMARK 465 ASN B 11 REMARK 465 PHE B 106 REMARK 465 LYS B 107 REMARK 465 LYS B 108 REMARK 465 GLU B 109 REMARK 465 GLU B 110 REMARK 465 GLY B 111 REMARK 465 TYR B 112 REMARK 465 GLY B 113 REMARK 465 LYS B 114 REMARK 465 LYS B 152 REMARK 465 LYS B 153 REMARK 465 GLY B 154 REMARK 465 GLY B 155 REMARK 465 LYS B 204 REMARK 465 PRO B 205 REMARK 465 LEU B 206 REMARK 465 VAL B 207 REMARK 465 LEU B 208 REMARK 465 THR B 209 REMARK 465 GLY B 210 REMARK 465 SER B 211 REMARK 465 LEU B 212 REMARK 465 ASP B 213 REMARK 465 GLY B 214 REMARK 465 SER B 215 REMARK 465 PHE B 216 REMARK 465 LEU B 217 REMARK 465 ALA B 218 REMARK 465 SER B 219 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASN A 11 CG OD1 ND2 REMARK 470 ASP A 53 CG OD1 OD2 REMARK 470 LYS A 54 CG CD CE NZ REMARK 470 LYS A 55 CG CD CE NZ REMARK 470 LYS A 68 CG CD CE NZ REMARK 470 LYS A 107 CG CD CE NZ REMARK 470 LYS A 108 CG CD CE NZ REMARK 470 GLU A 109 CG CD OE1 OE2 REMARK 470 SER A 150 OG REMARK 470 LYS A 171 CG CD CE NZ REMARK 470 LYS A 204 CG CD CE NZ REMARK 470 LYS A 262 CG CD CE NZ REMARK 470 LYS A 304 CG CD CE NZ REMARK 470 LYS A 305 CG CD CE NZ REMARK 470 PHE B 12 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS B 54 CG CD CE NZ REMARK 470 LYS B 55 CG CD CE NZ REMARK 470 LYS B 101 CG CD CE NZ REMARK 470 LYS B 149 CG CD CE NZ REMARK 470 LYS B 171 CG CD CE NZ REMARK 470 PHE B 220 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS B 263 CG CD CE NZ REMARK 470 PHE B 302 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS B 304 CG CD CE NZ REMARK 470 LYS B 305 CG CD CE NZ REMARK 470 LYS B 307 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 179 56.21 -118.32 REMARK 500 LEU A 203 79.17 -108.12 REMARK 500 ASN A 255 50.04 -92.79 REMARK 500 SER B 150 -157.61 -118.56 REMARK 500 TYR B 179 53.49 -119.25 REMARK 500 ASN B 255 50.09 -93.51 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 CDL A 800 REMARK 610 CDL A 801 REMARK 610 CDL A 802 REMARK 610 CDL B 800 REMARK 610 CDL B 801 REMARK 610 CDL B 802 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CXT A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CDL A 800 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CDL A 801 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CDL A 802 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CXT B 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CDL B 800 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CDL B 801 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CDL B 802 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4C9G RELATED DB: PDB REMARK 900 STRUCTURE OF YEAST MITOCHONDRIAL ADP-ATP CARRIER ISOFORM 2 REMARK 900 INHIBITED BY CARBOXYATRACTYLOSIDE (C2221 CRYSTAL FORM) REMARK 900 RELATED ID: 4C9H RELATED DB: PDB REMARK 900 STRUCTURE OF YEAST MITOCHONDRIAL ADP-ATP CARRIER ISOFORM 2 REMARK 900 INHIBITED BY CARBOXYATRACTYLOSIDE (P212121 CRYSTAL FORM) REMARK 900 RELATED ID: 4C9Q RELATED DB: PDB REMARK 900 STRUCTURE OF YEAST MITOCHONDRIAL ADP-ATP CARRIER ISOFORM 3 REMARK 900 INHIBITED BY CARBOXYATRACTYLOSIDE (P21 CRYSTAL FORM) DBREF 4C9J A 3 307 UNP P18238 ADT3_YEAST 3 307 DBREF 4C9J B 3 307 UNP P18238 ADT3_YEAST 3 307 SEQADV 4C9J MET A -14 UNP P18238 EXPRESSION TAG SEQADV 4C9J HIS A -13 UNP P18238 EXPRESSION TAG SEQADV 4C9J HIS A -12 UNP P18238 EXPRESSION TAG SEQADV 4C9J HIS A -11 UNP P18238 EXPRESSION TAG SEQADV 4C9J HIS A -10 UNP P18238 EXPRESSION TAG SEQADV 4C9J HIS A -9 UNP P18238 EXPRESSION TAG SEQADV 4C9J HIS A -8 UNP P18238 EXPRESSION TAG SEQADV 4C9J HIS A -7 UNP P18238 EXPRESSION TAG SEQADV 4C9J HIS A -6 UNP P18238 EXPRESSION TAG SEQADV 4C9J HIS A -5 UNP P18238 EXPRESSION TAG SEQADV 4C9J ILE A -4 UNP P18238 EXPRESSION TAG SEQADV 4C9J GLU A -3 UNP P18238 EXPRESSION TAG SEQADV 4C9J GLY A -2 UNP P18238 EXPRESSION TAG SEQADV 4C9J ARG A -1 UNP P18238 EXPRESSION TAG SEQADV 4C9J SER A 0 UNP P18238 EXPRESSION TAG SEQADV 4C9J MET A 1 UNP P18238 EXPRESSION TAG SEQADV 4C9J ALA A 2 UNP P18238 EXPRESSION TAG SEQADV 4C9J MET B -14 UNP P18238 EXPRESSION TAG SEQADV 4C9J HIS B -13 UNP P18238 EXPRESSION TAG SEQADV 4C9J HIS B -12 UNP P18238 EXPRESSION TAG SEQADV 4C9J HIS B -11 UNP P18238 EXPRESSION TAG SEQADV 4C9J HIS B -10 UNP P18238 EXPRESSION TAG SEQADV 4C9J HIS B -9 UNP P18238 EXPRESSION TAG SEQADV 4C9J HIS B -8 UNP P18238 EXPRESSION TAG SEQADV 4C9J HIS B -7 UNP P18238 EXPRESSION TAG SEQADV 4C9J HIS B -6 UNP P18238 EXPRESSION TAG SEQADV 4C9J HIS B -5 UNP P18238 EXPRESSION TAG SEQADV 4C9J ILE B -4 UNP P18238 EXPRESSION TAG SEQADV 4C9J GLU B -3 UNP P18238 EXPRESSION TAG SEQADV 4C9J GLY B -2 UNP P18238 EXPRESSION TAG SEQADV 4C9J ARG B -1 UNP P18238 EXPRESSION TAG SEQADV 4C9J SER B 0 UNP P18238 EXPRESSION TAG SEQADV 4C9J MET B 1 UNP P18238 EXPRESSION TAG SEQADV 4C9J ALA B 2 UNP P18238 EXPRESSION TAG SEQRES 1 A 322 MET HIS HIS HIS HIS HIS HIS HIS HIS HIS ILE GLU GLY SEQRES 2 A 322 ARG SER MET ALA SER ASP ALA LYS GLN GLN GLU THR ASN SEQRES 3 A 322 PHE ALA ILE ASN PHE LEU MET GLY GLY VAL SER ALA ALA SEQRES 4 A 322 ILE ALA LYS THR ALA ALA SER PRO ILE GLU ARG VAL LYS SEQRES 5 A 322 ILE LEU ILE GLN ASN GLN ASP GLU MET ILE LYS GLN GLY SEQRES 6 A 322 THR LEU ASP LYS LYS TYR SER GLY ILE VAL ASP CYS PHE SEQRES 7 A 322 LYS ARG THR ALA LYS GLN GLU GLY LEU ILE SER PHE TRP SEQRES 8 A 322 ARG GLY ASN THR ALA ASN VAL ILE ARG TYR PHE PRO THR SEQRES 9 A 322 GLN ALA LEU ASN PHE ALA PHE LYS ASP LYS ILE LYS LEU SEQRES 10 A 322 MET PHE GLY PHE LYS LYS GLU GLU GLY TYR GLY LYS TRP SEQRES 11 A 322 PHE ALA GLY ASN LEU ALA SER GLY GLY ALA ALA GLY ALA SEQRES 12 A 322 LEU SER LEU LEU PHE VAL TYR SER LEU ASP PHE ALA ARG SEQRES 13 A 322 THR ARG LEU ALA ALA ASP ALA LYS SER SER LYS LYS GLY SEQRES 14 A 322 GLY ALA ARG GLN PHE ASN GLY LEU THR ASP VAL TYR LYS SEQRES 15 A 322 LYS THR LEU LYS SER ASP GLY ILE ALA GLY LEU TYR ARG SEQRES 16 A 322 GLY PHE MET PRO SER VAL VAL GLY ILE VAL VAL TYR ARG SEQRES 17 A 322 GLY LEU TYR PHE GLY MET PHE ASP SER LEU LYS PRO LEU SEQRES 18 A 322 VAL LEU THR GLY SER LEU ASP GLY SER PHE LEU ALA SER SEQRES 19 A 322 PHE LEU LEU GLY TRP VAL VAL THR THR GLY ALA SER THR SEQRES 20 A 322 CYS SER TYR PRO LEU ASP THR VAL ARG ARG ARG MET MET SEQRES 21 A 322 MET THR SER GLY GLN ALA VAL LYS TYR ASN GLY ALA ILE SEQRES 22 A 322 ASP CYS LEU LYS LYS ILE VAL ALA SER GLU GLY VAL GLY SEQRES 23 A 322 SER LEU PHE LYS GLY CYS GLY ALA ASN ILE LEU ARG SER SEQRES 24 A 322 VAL ALA GLY ALA GLY VAL ILE SER MET TYR ASP GLN LEU SEQRES 25 A 322 GLN MET ILE LEU PHE GLY LYS LYS PHE LYS SEQRES 1 B 322 MET HIS HIS HIS HIS HIS HIS HIS HIS HIS ILE GLU GLY SEQRES 2 B 322 ARG SER MET ALA SER ASP ALA LYS GLN GLN GLU THR ASN SEQRES 3 B 322 PHE ALA ILE ASN PHE LEU MET GLY GLY VAL SER ALA ALA SEQRES 4 B 322 ILE ALA LYS THR ALA ALA SER PRO ILE GLU ARG VAL LYS SEQRES 5 B 322 ILE LEU ILE GLN ASN GLN ASP GLU MET ILE LYS GLN GLY SEQRES 6 B 322 THR LEU ASP LYS LYS TYR SER GLY ILE VAL ASP CYS PHE SEQRES 7 B 322 LYS ARG THR ALA LYS GLN GLU GLY LEU ILE SER PHE TRP SEQRES 8 B 322 ARG GLY ASN THR ALA ASN VAL ILE ARG TYR PHE PRO THR SEQRES 9 B 322 GLN ALA LEU ASN PHE ALA PHE LYS ASP LYS ILE LYS LEU SEQRES 10 B 322 MET PHE GLY PHE LYS LYS GLU GLU GLY TYR GLY LYS TRP SEQRES 11 B 322 PHE ALA GLY ASN LEU ALA SER GLY GLY ALA ALA GLY ALA SEQRES 12 B 322 LEU SER LEU LEU PHE VAL TYR SER LEU ASP PHE ALA ARG SEQRES 13 B 322 THR ARG LEU ALA ALA ASP ALA LYS SER SER LYS LYS GLY SEQRES 14 B 322 GLY ALA ARG GLN PHE ASN GLY LEU THR ASP VAL TYR LYS SEQRES 15 B 322 LYS THR LEU LYS SER ASP GLY ILE ALA GLY LEU TYR ARG SEQRES 16 B 322 GLY PHE MET PRO SER VAL VAL GLY ILE VAL VAL TYR ARG SEQRES 17 B 322 GLY LEU TYR PHE GLY MET PHE ASP SER LEU LYS PRO LEU SEQRES 18 B 322 VAL LEU THR GLY SER LEU ASP GLY SER PHE LEU ALA SER SEQRES 19 B 322 PHE LEU LEU GLY TRP VAL VAL THR THR GLY ALA SER THR SEQRES 20 B 322 CYS SER TYR PRO LEU ASP THR VAL ARG ARG ARG MET MET SEQRES 21 B 322 MET THR SER GLY GLN ALA VAL LYS TYR ASN GLY ALA ILE SEQRES 22 B 322 ASP CYS LEU LYS LYS ILE VAL ALA SER GLU GLY VAL GLY SEQRES 23 B 322 SER LEU PHE LYS GLY CYS GLY ALA ASN ILE LEU ARG SER SEQRES 24 B 322 VAL ALA GLY ALA GLY VAL ILE SER MET TYR ASP GLN LEU SEQRES 25 B 322 GLN MET ILE LEU PHE GLY LYS LYS PHE LYS HET CXT A 401 51 HET CDL A 800 38 HET CDL A 801 46 HET CDL A 802 43 HET CXT B 401 51 HET CDL B 800 36 HET CDL B 801 40 HET CDL B 802 41 HETNAM CXT CARBOXYATRACTYLOSIDE HETNAM CDL CARDIOLIPIN HETSYN CDL DIPHOSPHATIDYL GLYCEROL; BIS-(1,2-DIACYL-SN-GLYCERO-3- HETSYN 2 CDL PHOSPHO)-1',3'-SN-GLYCEROL FORMUL 3 CXT 2(C31 H46 O18 S2) FORMUL 4 CDL 6(C81 H156 O17 P2 2-) HELIX 1 1 THR A 10 ALA A 30 1 21 HELIX 2 2 ALA A 30 ASN A 42 1 13 HELIX 3 3 ASN A 42 GLN A 49 1 8 HELIX 4 4 GLY A 58 GLU A 70 1 13 HELIX 5 5 LEU A 72 ARG A 77 5 6 HELIX 6 6 GLY A 78 ARG A 85 1 8 HELIX 7 7 ARG A 85 GLY A 105 1 21 HELIX 8 8 GLY A 111 ASP A 147 1 37 HELIX 9 9 GLY A 161 ASP A 173 1 13 HELIX 10 10 GLY A 174 TYR A 179 1 6 HELIX 11 11 GLY A 181 LEU A 203 1 23 HELIX 12 12 LEU A 221 SER A 234 1 14 HELIX 13 13 SER A 234 SER A 248 1 15 HELIX 14 14 GLY A 256 GLY A 269 1 14 HELIX 15 15 VAL A 270 LYS A 275 5 6 HELIX 16 16 GLY A 276 PHE A 302 1 27 HELIX 17 17 PHE B 12 ALA B 30 1 19 HELIX 18 18 ALA B 30 ASN B 42 1 13 HELIX 19 19 ASN B 42 GLN B 49 1 8 HELIX 20 20 GLY B 58 GLU B 70 1 13 HELIX 21 21 LEU B 72 ARG B 77 5 6 HELIX 22 22 GLY B 78 ARG B 85 1 8 HELIX 23 23 ARG B 85 PHE B 104 1 20 HELIX 24 24 TRP B 115 ASP B 147 1 33 HELIX 25 25 GLY B 161 ASP B 173 1 13 HELIX 26 26 GLY B 174 TYR B 179 1 6 HELIX 27 27 GLY B 181 LEU B 203 1 23 HELIX 28 28 LEU B 221 SER B 234 1 14 HELIX 29 29 SER B 234 THR B 247 1 14 HELIX 30 30 GLY B 256 GLY B 269 1 14 HELIX 31 31 VAL B 270 LYS B 275 5 6 HELIX 32 32 GLY B 276 PHE B 302 1 27 SITE 1 AC1 8 ARG A 85 ASN A 93 LYS A 97 GLY A 188 SITE 2 AC1 8 ARG A 193 SER A 234 ASP A 238 ARG A 241 SITE 1 AC2 11 TRP A 76 ARG A 77 GLY A 78 ASN A 79 SITE 2 AC2 11 THR A 80 LEU A 162 THR A 163 CDL A 801 SITE 3 AC2 11 LEU B 72 ILE B 73 CDL B 800 SITE 1 AC3 12 ILE A 40 GLY A 58 ILE A 59 VAL A 60 SITE 2 AC3 12 LYS A 167 LEU A 170 PHE A 274 GLY A 276 SITE 3 AC3 12 GLY A 278 ILE A 281 LEU A 282 CDL A 800 SITE 1 AC4 13 ILE A 175 ALA A 176 TYR A 179 GLY A 181 SITE 2 AC4 13 PHE A 182 MET A 183 VAL A 187 LEU A 237 SITE 3 AC4 13 MET A 244 GLY A 256 ALA A 257 ILE A 258 SITE 4 AC4 13 PHE B 116 SITE 1 AC5 9 ARG B 85 ASN B 93 LYS B 97 SER B 130 SITE 2 AC5 9 GLY B 188 ARG B 193 SER B 234 ASP B 238 SITE 3 AC5 9 ARG B 241 SITE 1 AC6 10 LEU A 72 CDL A 800 TRP B 76 ARG B 77 SITE 2 AC6 10 GLY B 78 ASN B 79 THR B 80 GLY B 161 SITE 3 AC6 10 LEU B 162 THR B 163 SITE 1 AC7 11 SER B 57 GLY B 58 ILE B 59 VAL B 60 SITE 2 AC7 11 LYS B 167 PHE B 274 GLY B 276 CYS B 277 SITE 3 AC7 11 GLY B 278 ALA B 279 ILE B 281 SITE 1 AC8 12 LEU B 132 ILE B 175 ALA B 176 TYR B 179 SITE 2 AC8 12 GLY B 181 PHE B 182 MET B 183 PRO B 184 SITE 3 AC8 12 LEU B 237 GLY B 256 ALA B 257 ILE B 258 CRYST1 40.286 104.168 154.143 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.024823 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009600 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006487 0.00000 MTRIX1 1 0.997510 -0.066490 -0.023510 -8.40705 1 MTRIX2 1 -0.063320 -0.991160 0.116560 -22.94266 1 MTRIX3 1 -0.031050 -0.114780 -0.992910 353.53979 1